ACCURETIC

Brand name authorized in: Australia Canada Ireland Italy New Zealand United Kingdom United States

Active ingredients

The drug ACCURETIC contains a combination of these active pharmaceutical ingredients (APIs):

1 Quinapril
UNII 33067B3N2M - QUINAPRIL HYDROCHLORIDE

Quinapril is a potent angiotensin-converting enzyme (ACE) inhibitor. The mode of action of quinapril in humans and animals is to inhibit circulating and tissue ACE activity, thereby decreasing vasopressor activity and aldosterone secretion.

Read about Quinapril
2 Hydrochlorothiazide
UNII 0J48LPH2TH - HYDROCHLOROTHIAZIDE

Hydrochlorothiazide is a diuretic and an antihypertensive agent. It affects the distal renal tubular mechanism of electrolyte reabsorption and increases excretion of sodium and chloride in approximately equivalent amounts.

Read about Hydrochlorothiazide

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code
Group title
Classification
C09BA06
Quinapril and diuretics
C Cardiovascular system → C09 Agents acting on the renin-angiotensin system → C09B ACE inhibitors, combinations → C09BA ACE inhibitors and diuretics
Discover more medicines within C09BA06

Unique identifiers

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country
Identification scheme
Identifier(s)
AU
Pharmaceutical Benefits Scheme
Identifier(s): 8589C, 8590D
CA
Health Products and Food Branch
Identifier(s): 02237367, 02237368, 02237369
GB
Medicines & Healthcare Products Regulatory Agency
Identifier(s): 140360, 161332, 26056
IE
Health Products Regulatory Authority
Identifier(s): 10092
IT
Agenzia Italiana del Farmaco
Identifier(s): 028295018
NZ
Medicines and Medical Devices Safety Authority
Identifier(s): 9643, 9644
US
FDA, National Drug Code
Identifier(s): 0071-0220, 0071-0222, 0071-0223